ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

NCI, CDC To Collaborate On Surveillance System.

March 24, 2000

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011